Literature DB >> 2413613

Vascular permeability of pancreatic islets after administration of streptozotocin.

S Sandler, L Jansson.   

Abstract

In the present study we have investigated whether the pancreatic B-cell toxic agent streptozotocin (SZ) induces increased vascular permeability as an indicator of lesions in the pancreatic islets. SZ was given either in multiple low doses, providing an animal model for Type I diabetes mellitus with signs of autoimmunity, or by a single diabetogenic dose to C57BL/KsJ mice. The vascular reactions were detected by administration of Monastral blue B and the pancreatic islets were visualized by a freeze-thawing technique which made it possible to count the number of stained and unstained islets. This proved to be a rapid and sensitive technique for detection of early lesions within the islets after administration of SZ. It was found that the islets showed an increased vascular staining before the animals had become diabetic by either mode of SZ treatment and also before signs of pancreatic insulitis were found after the multiple low-dose injections of SZ. It is suggested that both types of SZ administration induce a B-cytotoxic reaction, essential for the development of hyperglycaemia. This leads to an activation of cells dealing with the disposal of cell debris, a process which probably also involves the release of substances mediating increased vascular permeability.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413613     DOI: 10.1007/bf00709983

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  18 in total

1.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

2.  Streptozotocin- and alloxan-diabetes in mice.

Authors:  C Rerup; F Tarding
Journal:  Eur J Pharmacol       Date:  1969-07       Impact factor: 4.432

3.  A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non-radioactive microspheres.

Authors:  L Jansson; C Hellerström
Journal:  Acta Physiol Scand       Date:  1981

4.  The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro.

Authors:  S Sandler; A Andersson
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

5.  Protection by dimethyl urea against hyperglycaemia, but not insulitis, in low-dose streptozotocin-induced diabetes in the mouse.

Authors:  S Sandler
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

6.  Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.

Authors:  S G Paik; N Fleischer; S I Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

7.  Vascular labelling with monastral blue B.

Authors:  I Joris; U DeGirolami; K Wortham; G Majno
Journal:  Stain Technol       Date:  1982-05

8.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

9.  Diabetes susceptibility of BALB/cBOM mice treated with streptozotocin. Inhibition by lethal irradiation and restoration by splenic lymphocytes.

Authors:  S G Paik; M L Blue; N Fleischer; S Shin
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

10.  Islet implantation into diabetic mice with pancreatic insulitis.

Authors:  S Sandler; A Andersson
Journal:  Acta Pathol Microbiol Scand A       Date:  1981-03
View more
  15 in total

1.  Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes.

Authors:  Stuart E Turvey; Eric Swart; Maria C Denis; Umar Mahmood; Christophe Benoist; Ralph Weissleder; Diane Mathis
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

2.  Imaging the pancreatic vasculature in diabetes models.

Authors:  Zdravka Medarova; Dale L Greiner; Marytheresa Ifediba; Guangping Dai; Elijah Bolotin; Gerardo Castillo; Alexei Bogdanov; Mohanraja Kumar; Anna Moore
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

3.  Alloxan-induced diabetes in the mouse: time course of pancreatic B-cell destruction as reflected in an increased islet vascular permeability.

Authors:  L Jansson; S Sandler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Pathogenesis of low dose streptozotocin induced diabetes in mice: requirement for alpha 1-adrenoceptor activation and vasoactive amine release.

Authors:  S Martin; V Kolb-Bachofen; U Kiesel; H Kolb
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

Review 5.  Diagnostic and prognostic utility of non-invasive imaging in diabetes management.

Authors:  Cristina Barsanti; Francesca Lenzarini; Claudia Kusmic
Journal:  World J Diabetes       Date:  2015-06-25

6.  Plasticity of Schwann cells and pericytes in response to islet injury in mice.

Authors:  Shiue-Cheng Tang; Yu-Chen Chiu; Chia-Tung Hsu; Shih-Jung Peng; Ya-Yuan Fu
Journal:  Diabetologia       Date:  2013-06-26       Impact factor: 10.122

7.  A pancreatic venular defect in the BB/Wor rat.

Authors:  G Majno; I Joris; E S Handler; J Desemone; J P Mordes; A A Rossini
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

8.  Alterations of islet microvasculature in mice treated with low-dose streptozocin.

Authors:  G Papaccio; G Chieffi-Baccari
Journal:  Histochemistry       Date:  1992-05

9.  Increased vascular permeability in pancreas of diabetic rats: detection with high resolution protein A-gold cytochemistry.

Authors:  M E De Paepe; M Corriveau; W N Tannous; T A Seemayer; E Colle
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

10.  Imaging inflammation of the pancreatic islets in type 1 diabetes.

Authors:  Maria C Denis; Umar Mahmood; Christophe Benoist; Diane Mathis; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.